Abstract-Increased intraglomerular pressure is considered a major factor for increased albumin excretion in hypertension.
M
icroalbuminuria is a recently recognized link between cardiovascular and renal damage in hypertensive diabetic and nondiabetic subjects. 1, 2 Many patients with high blood pressure have a renal abnormality. However, the exact relationship between increased glomerular pressure that may be derived from increases in systemic blood pressure, or the specific increases in local intraglomerular pressure without similar changes in systemic pressure and glomerular malfunction have yet to be determined.
Although the underlying mechanism responsible for albuminuria in hypertension remains speculative, recent studies suggest that factors other than changes in glomerular permeability should be considered. These studies have demonstrated that albumin excretion in healthy controls is associated with comprehensive degradation (Ͼ95%) by lysosomes in renal cells distal to the glomerular basement membrane (GBM). 3 Previously it was assumed that virtually all proteins filtered by the kidney were excreted intact. In fact Ͻ5% of albumin is excreted intact and detectable by conventional immunochemical assays. The remaining Ͼ95% is degraded and undetectable by routine immunochemical assays. The lysosomal processing of filtered albumin before its excretion has been shown to be an extremely rapid and efficient process. It occurs within minutes and involves lysosomal uptake and exocytosis of peptide products back to the tubular lumen by renal cells distal to the GBM. [3] [4] [5] [6] [7] [8] There is negligible contribution of albumin fragments arising from proteolytic activity on the luminal surface of the tubular cells, 9 from extra renal sources, 3 or from contraluminal uptake of albumin with subsequent degradation. 10 Similar rapid lysosomal processing has been demonstrated in vivo associated with the filtration and excretion of dextran sulfate in which the dextran sulfate is completely desulfated but not depolymerized. 11 The ratio of intact to degraded forms of albumin and dextran sulfate has been shown previously to increase in experimental diabetic nephropathy. 11 The increased ratio of intact to degraded albumin has also been shown in type 1 diabetic patients with diabetic nephropathy. 4 Furthermore, aminoguanidine (an antiglycation agent) and ramipril (an ACE inhibitor) have been demonstrated to normalize the protein fragmentation/desulfation process in rats with streptozotocin-induced diabetic nephropathy. 11 These results may be linked to changes in transforming growth factor-␤ (TGF-␤) expression, which is upregulated in diabetes and other kidney disease states 12 and may be upregulated in hypertension as a result of increased stretching forces [13] [14] [15] brought about by the hypertensive state. Recent studies have shown that lysosomal activity may be affected by increased TGF-␤ levels, 16 and its role in albuminuria induction may be further supported by the fact that ACE inhibitors and decreasing albuminuria are correlated with decreased TGF-␤ levels, 17 which leads to the hypothesis to be tested in this study.
Normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) male rats were used to study the nature of urinary albumin excretion associated with the hypertensive state. Changes in lysosomal processing were determined by size exclusion chromatography analysis of urinary [
14 C]albumin administered by osmotic pump. Ion exchange chromatographic analysis of urinary [ 3 H]dextran sulfate administered intravenously was used to determine changes in lysosomal sulfatase activity. These changes were correlated with changes in renal TGF-␤1 expression as determined by realtime quantitative reverse transcription polymerase chain reaction (RT-PCR) for TGF-␤1 mRNA and further confirmed with the upregulation of the TGF-␤-inducible gene-h3 18 (␤ig-h3) mRNA, also by RT-PCR. Changes in glomerular permeability in hypertension were determined using the osmotic pump method to measure the fractional clearance 
Methods

Experimental Animals
Male SHR (nϭ24) and WKY (nϭ24) weighing 200 to 250g were obtained from the Australian Resource Center (Perth, Australia). Rats were housed in rat boxes, under a 12-hour/12-hour day/night cycle with free access to standard rat chow and water for 8, 16, or 24 weeks. Systolic blood pressure was measured by tail-cuff plethysmography 19 in conscious warmed rats. 22 Rats were anesthetized by Forthane (Abbott Australasia Pty Ltd) inhalation. Blood and urine samples were analyzed for radioactivity as previously described 22 and by radioimmunoassay (RIA). Glomerular filtration rate (GFR) was determined by creatinine assay. 23 Column Chromatography [ 14 C]Albumin in plasma and urine samples was analyzed using a Sephadex G-50 column (column dimensions, 18 cmϫ1 cm 2 ; Pharmacia Fine Chemicals). [ 3 H]Ficoll-70 in plasma and urine samples was fractionated using an S-300 column (column dimensions, 62 cmϫ1.6 cm 2 ; Pharmacia Fine Chemicals). The run conditions have been described previously. 22 
Radiolabeling of Proteins
where V e is the elution volume; V o , the void volume; and V t , the total volume of the column.
The K av for radiolabeled albumin, transferrin, and IgG on Sephacryl S-300 was 0.464, 0.424, and 0.332, respectively. The Fc of [ 3 H]Ficoll corresponding to these radii was determined by calculating the elution of [ 3 H]Ficoll (dpm/mL) at the corresponding K av in urine and plasma samples.
Analysis of Dextran Sulfate Desulfation
Two milligrams [ 3 H]dextran sulfate was injected intravenously into 24-week rats. Three-hour urine and corresponding plasma sample was taken and analyzed via ion exchange chromatography using a 19 cmϫ1 cm 2 Q-Sepharose column (Pharmacia Fine Chemicals). The sample was applied in 6 mol/L urea, 0.05 mol/L Tris, 0.05% CHAPS, and 0.15 mol/L NaCl (pH 7.0) and eluted with a linear gradient of 1 mol/L to 2.5 mol/L NaCl in the same buffer. The percent intact dextran sulfate was determined using the area under the curve for intact dextran sulfate compared with total dextran sulfate elution.
Albumin Radioimmunoassay
125
I-labeled RSA was prepared using the chloramine T method. 24 The urinary albumin concentration was measured using a double antibody RIA. The interassay coefficient variation was 7% at a concentration of 180 g/L. The detection limit of the assay was 31.2 g/L.
RT-PCR
cDNA was synthesized with the Superscript First Strand synthesis system for RT-PCR (GIBCO BRL). Renal TGF-␤1 and ␤ig-h3 mRNA expression were analyzed by real-time quantitative RT-PCR (TaqMan system) as previously described. 25 Primers and TaqMan probe for TGF-␤1 and the endogenous reference 18S rRNA were constructed by Primer Express (ABI Prism 7700, Perkin-Elmer Inc): TGF-␤1 forward primer, 5Ј-TTGCCCTCTACAACCAACACAA-3Ј; reverse primer, 5Ј-GGCTTGCGACCCACGTAGTA-3Ј. TGF-␤1-specific probe was FAM-5Ј-CCGGGTGCTTCCGCATCACC-3Ј-TAMRA; FAM is 6 carboxyfluorescein; TAMRA (quencher) is 6-carboxy-tetramethylrhodamine. ␤ig-h3 forward primer was 5Ј-TCTGCATTGAAAACAGCTGCAT-3Ј; reverse primer, 5Ј-CAGCATCCGGTCCATGGT-3Ј. ␤ig-h3-specific probe was FAM-5Ј-CAGGGTCCCATACCGTCCCTTCTTGT-3Ј-TAMRA. Results expressed relative to control kidneys, which were arbitrarily assigned a value of 1.
Statistics
All data are expressed as meanϮSD, where n is the number of determinations. The Student's t test was used to determine probability where PϽ0.05 was taken as statistically significant.
Equations
Fc was determined using the following equation: Fcϭ[urinary albumin/plasma albumin]ϫ[UFR/GFR], where UFR is the urine flow rate (mL/min).
Total albumin (intact plus fragments) excretion was calculated using the following equation: [plasma albumin (in mg/mL)]/[plasma albumin (in dpm/mL)]ϫ[urine albumin (intact plus fragments, in dpm/mL)]ϫ[urine volume (in mL/24h)], where plasma albumin (mg/mL) is determined by RIA.
Percent intact albumin was determined using the following equation: [RIA intact albumin (in mg/24h)/total albumin (in mg/24h)]ϫ[100 /1] An expanded Methods section can be found in an online data supplement available at http://www.hypertensionaha.org.
Results
Physiological Parameters
The results in the intact with no fragments present. The increased excretion rate of intact albumin would not appear to be due to hyperfiltration, as there was no significant difference in the GFR between WKY and SHR studied at 24 weeks (Table) .
Glomerular Permeability
Ficoll has a globular structure and is not reabsorbed by the tubules, 26, 27 so it represents a suitable model for the glomerular permeability of globular proteins. The results in Figure 2 demonstrate that there is no significant change in glomerular permeability to molecules of radii 36 Å, 48 Å, or 55 Å in SHR compared with WKY. 
Physiological Parameters Associated with SHR and WKY
Fc of [ 14 C]Albumin
The Fc of intact albumin by RIA in the SHR increased over the 8-to 24-week period, giving rise to the apparent albuminuria. This increase was not accompanied by any increase in the Fc of total albumin (intact plus fragments as determined by radioactivity) over the same time period (Figure 3 ). Normotensive WKY showed only a slight increase in clearance of intact albumin over the 8-to 24-week period, consistent with aging. Similar results were obtained when examined in terms of excretion rates (Figure 4) . The Fc or excretion rate obtained from radioactivity is (1) ; nϭ6) but is still considerably lower than the Fc of Ficoll of equivalent molecular radius of 48 Å. The lack of change in the Fc of the radiolabeled proteins demonstrates that the combination of glomerular permeability and tubular reabsorption of these proteins is not affected in SHR. Thus, what is observed in hypertension is an increase in the amount of intact albumin excreted, giving rise to significant intact albuminuria, without any change in the net amount of albumin excreted.
Lysosomal Activity
The desulfation of dextran sulfate is affected by lysosomal sulfatases and may be considered as a marker of in vivo renal lysosomal activity. In 24-week WKY, the amount of intact urinary dextran sulfate is 2.76%Ϯ1.08% (nϭ4; compared with intact albumin of 0.82%Ϯ0.63%), whereas in 24-week SHR, the amount of intact dextran sulfate is 6.75%Ϯ1.54% (nϭ6, PϽ0.005; with intact albumin at 6.82%Ϯ3.97%). The increase in the amount of intact dextran sulfate in the urine of SHR, in parallel with the increased excretion of intact albumin provides further evidence that lysosomal processing is directly associated with the increased levels of intact albumin in the urine of hypertensive rats.
Renal TGF-␤1 and ␤ig-h3 mRNA Expression Figure 5a shows an increase in renal TGF-␤1 mRNA in the SHR group at all time points. Increased translation of TGF-␤1 was confirmed by increased renal ␤ig-h3 mRNA (Figure 5b ) (expression of which is induced by increased TGF-␤ production 18 ). Renal TGF-␤1 levels increased in all groups in parallel with increased intact albumin excretion and decreased lysosomal activity.
Discussion
A widely recognized mechanism of albuminuria associated with hypertension is that caused by glomerular hyperfiltration, which may increase albumin filtration and which in turn may exert toxic effects on renal cells. 28 -30 The present studies have demonstrated that although there were significant increases in systemic blood pressure in SHR, there was no corresponding increase in GFR. This would be consistent with observations that both the excretion rate and Fc of intact albumin plus albumin-derived fragments, as determined by radioactivity, do not change over the 24 weeks studied. This means that some other factor must be responsible for the increased intact albuminuria in hypertension.
It is unlikely that alterations in the permeability of the glomerular capillary wall could account for the observed increase in intact albuminuria. We have demonstrated in this study that changes in the permeability of the glomerular capillary wall were not apparent when Ficoll Fc was measured. Further, there was no change in the excretion rate and Fc of radiolabeled albumin and transferrin, and thus the combination of glomerular permeability and tubular uptake was also not altered. This would also eliminate the possibility of a saturation of the lysosomal degradation pathway, giving rise to an overflow of intact albumin. In addition, we have previously established that glomerular charge selectivity is not a factor, as studies have demonstrated this to be negligible. 8, 31, 32 This can be rationalized with previous studies of charge selectivity, in which charged transport probes have been shown to be biochemically altered during filtration and renal passage, resulting in profound effects on clearance measurements. Before excretion, dextran sulfate is desulfated, 31 and charged proteins are degraded to peptides. [3] [4] [5] [6] [7] [8] All these measurements suggest that there was no change in kidney function in the SHR.
Yet, it is important to note that the values of the fractional clearances associated with the clearance of Ficoll and radiolabeled proteins are an order of magnitude higher than that seen for the changes in excretion of intact albumin in hypertension. This means that these types of measurements, including GFR, could be insensitive to the changes observed for intact albumin excretion. The only corresponding change is the increased excretion of intact dextran sulfate, in which lysosomal sulfatase activity has been reduced in hypertension. Similar findings have been made for the parallel increase in the excretion of intact albumin and dextran sulfate in streptozotocin-induced diabetic rats. 11 This increase could be inhibited by ramipril and aminoguanidine. 11 Thus, what is observed in hypertension is an increase in the amount of intact albumin excreted giving rise to significant intact albuminuria, without any change in the net amount of albumin excreted.
The new finding of similar changes in the renal processing of albumin and dextran sulfate suggests that the changes in lysosomal processing represent a specific metabolic event closely linked to a rise in blood pressure. A possible linkage factor is the role of TGF-␤. This growth factor is known to decrease lysosomal enzyme activities, 16 with increased production of TGF-␤ by mesangial cells when subjected to stretching forces brought about by high intraglomerular pressures. [13] [14] [15] Our results suggest that TGF-␤ production in hypertension may be playing a role in albuminuria through this mechanism, with results showing decreased lysosomal activity with an upregulation of TGF-␤, resulting in increased intact albuminuria irrespective of changes in glomerular permeability and net albumin excretion. TGF-␤ increases have commonly been associated with kidney hypertrophy and TGF-␤ fibrogenic potential. 33 Here we describe a new link between TGF-␤ and the onset of kidney dysfunction in hypertension as determined by albuminuria. This supports approaches that recognize TGF-␤ as a therapeutic target 34 in nephrotic states. 
